Martingale Asset Management’s BioCryst Pharmaceuticals BCRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-54,055	Closed	-$334K	–	792
2024 Q2	$334K	Buy	54,055 +9,552	+21%	+$59K	0.01%	678
2024 Q1	$226K	Buy	44,503 +28,466	+178%	+$145K	﹤0.01%	757
2023 Q4	$96.1K	Buy	+16,037	New	+$96.1K	﹤0.01%	778